Immunomodulatory agents and cell therapy for patients with type 1 diabetes.

Rodacki M, Silva KR, Araujo DB, Dantas JR, Ramos MEN, Zajdenverg L, Baptista LS.

Open source

DOI
10.20945/2359-4292-2024-0233
Published
2025-04-11
Container
Arch Endocrinol Metab
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.20945/2359-4292-2024-0233,
  title = {Immunomodulatory agents and cell therapy for patients with type 1 diabetes.},
  author = {Rodacki M and  Silva KR and  Araujo DB and  Dantas JR and  Ramos MEN and  Zajdenverg L and  Baptista LS.},
  year = {2025},
  journal = {Arch Endocrinol Metab},
  doi = {10.20945/2359-4292-2024-0233},
  url = {https://doi.org/10.20945/2359-4292-2024-0233}
}

RIS

TY  - JOUR
TI  - Immunomodulatory agents and cell therapy for patients with type 1 diabetes.
AU  - Rodacki M
AU  -  Silva KR
AU  -  Araujo DB
AU  -  Dantas JR
AU  -  Ramos MEN
AU  -  Zajdenverg L
AU  -  Baptista LS.
PY  - 2025
JO  - Arch Endocrinol Metab
DO  - 10.20945/2359-4292-2024-0233
UR  - https://doi.org/10.20945/2359-4292-2024-0233
ER  - 

APA

M, R., KR, S., DB, A., JR, D., MEN, R., L, Z., & LS., B. (2025). Immunomodulatory agents and cell therapy for patients with type 1 diabetes.. Arch Endocrinol Metab. https://doi.org/10.20945/2359-4292-2024-0233

Source records